© 2002 European Society of Cardiology
Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure
a Department of Cardiology, University of Leipzig, Heart Center Strümpellstrasse 39, 04289 Leipzig, Germany
b Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital Harvard Medical School, Boston, MA, USA
c Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University of Leipzig Liebigstrasse 27a, 04103 Leipzig, Germany
* Corresponding author. Cardiovascular Research, Partners Research Facility, 65 Landsdowne Street, Room 289, Cambridge, MA 02139, USA. Tel.: +1-617-768-8283; fax: +1-617-768-8280 E-mail address: pcschulze{at}rics.bwh.harvard.edu
 |
Abstract |
|---|
Patients with chronic heart failure (CHF) have metabolic abnormalities, leading to a catabolic syndrome, with progressive loss of skeletal muscle in advanced stages of the disease. Leptin, the product of an obesity gene, has been associated with energy expenditure and weight regulation. The aim of this study was to assess serum levels of leptin and its soluble receptor in relation to exercise intolerance and neurohumoral activation in patients with CHF. We investigated 53 patients with CHF left ventricular ejection fraction (LVEF) 25±1%, age 56.6±1.3 years, Maximal oxygen uptake (VO2 max) 16.3±0.6 ml/min·kg) sub-classified according to peak oxygen consumption of > or 
14 ml/min·kg and 11 age-matched controls (LVEF 70±1, age 60.5±4.0 years, (VO2max) 26.9±1.6 ml/min·kg). Body mass index-adjusted serum levels of leptin and soluble leptin receptor were increased in patients with CHF compared to the controls (0.28±0.03 vs. 0.22±0.04 ng·m2/ml·kg and 32.6±1.9 ng/ml vs. 22.9±2.3, P<0.05). This increase was even more pronounced in patients with CHF and severe exercise intolerance (0.43±0.08 vs. 0.21±0.02 and 0.22±0.04 ng·m2/ml·kg; P<0.01 vs. VO2max>14 ml/min·kg and controls). Elevated levels of leptin correlated with an increased serum concentration of TNF
(r=0.749, P<0.01) in this subgroup of patients with CHF. We conclude that patients with advanced CHF show elevated serum levels of leptin and its soluble receptor. This finding indicates that leptin may participate in the catabolic state leading to the development of cardiac cachexia in the course of CHF.
Key Words: Leptin • Heart failure • Metabolism • Cytokines • Inflammation
Received July 12, 2002; Revised August 1, 2002; Accepted August 20, 2002
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. R. McGaffin, C. S. Moravec, and C. F. McTiernan Leptin Signaling in the Failing and Mechanically Unloaded Human Heart Circ Heart Fail, November 1, 2009; 2(6): 676 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Paulo Araujo, P. Lourenco, F. Rocha-Goncalves, A. Ferreira, and P. Bettencourt Adiponectin is increased in cardiac cachexia irrespective of body mass index Eur J Heart Fail, June 1, 2009; 11(6): 567 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Lieb, L. M. Sullivan, T. B. Harris, R. Roubenoff, E. J. Benjamin, D. Levy, C. S. Fox, T. J. Wang, P. W. Wilson, W. B. Kannel, et al. Plasma Leptin Levels and Incidence of Heart Failure, Cardiovascular Disease, and Total Mortality in Elderly Individuals Diabetes Care, April 1, 2009; 32(4): 612 - 616. [Abstract] [Full Text] [PDF]
|
|